Additional human cell/tissue‐focused studies are therefore required to address several open questions and to complement studies done in mice and other animal model systems: (1) Is there genetic evidence for YAP/TAZ hyperactivation in human skin cancers? The gene discussed is YAP1; the disease is skin neoplasm.